Long-acting glucose-dependent insulinotropic polypeptide ameliorates obesity-induced adipose tissue inflammation

Journal of Immunology

Volumn 193, Issue 8, 2014, Pages 4002-4009

  Varol, Chen ^a   Zvibel, Isabel ^a   Spektor, Lior ^a   Mantelmacher, Fernanda Dana ^a   Vugman, Milena ^a   Thurm, Tamar ^a   Khatib, Marian ^b   Elmaliah, Elinor ^a   Halpern, Zamir ^a   Fishman, Sigal ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CD4 ANTIGEN; CD8 ANTIGEN; FAT DROPLET; GAMMA INTERFERON; GASTRIC INHIBITORY POLYPEPTIDE; GLYCOPROTEIN P 15095; INSULIN; INTERLEUKIN 1BETA; LONG ACTING DRUG; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; RANTES; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, MOUSE; CCL5 PROTEIN, MOUSE; CCL8 PROTEIN, MOUSE; DIFFERENTIATION ANTIGEN; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GLUCOSE BLOOD LEVEL; HORMONE RECEPTOR; IL1B PROTEIN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL SIZE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNOREGULATION; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; LIVER; LY6CHI MONOCYTE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OBESITY; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; METABOLISM; NEUTROPHIL; PATHOLOGY; SECRETION (PROCESS); T LYMPHOCYTE SUBPOPULATION;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD11C; ANTIGENS, DIFFERENTIATION; ANTIGENS, LY; BLOOD GLUCOSE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CCL8; DIET, HIGH-FAT; GASTRIC INHIBITORY POLYPEPTIDE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERFERON-GAMMA; INTERLEUKIN-1BETA; LIPID DROPLETS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; NEUTROPHILS; OBESITY; RECEPTORS, GASTROINTESTINAL HORMONE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907546219     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401149     Document Type: Article

References (38)

1. Berrington de Gonzalez, A., P. Hartge, J. R. Cerhan, A. J. Flint, L. Hannan, R. J. MacInnis, S. C. Moore, G. S. Tobias, H. Anton-Culver, L. B. Freeman, et al. 2010. Body-mass index and mortality among 1.46 million white adults. N. Engl. J. Med. 363: 2211-2219.
2. Chawla, A., K. D. Nguyen, and Y. P. Goh. 2011. Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11: 738-749.
3. Guilherme, A., J. V. Virbasius, V. Puri, and M. P. Czech. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9: 367-377.
4. Osborn, O., and J. M. Olefsky. 2012. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18: 363-374.
5. Tilg, H., and A. R. Moschen. 2006. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6: 772-783.
6. Lumeng, C. N., J. L. Bodzin, and A. R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117: 175-184.
7. Lumeng, C. N., S. M. Deyoung, J. L. Bodzin, and A. R. Saltiel. 2007. Increased inflammatory properties of adipose tissue macrophages recruited during dietinduced obesity. Diabetes 56: 16-23.
8. Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, and H. Chen. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821-1830.
9. Weisberg, S. P., D. Hunter, R. Huber, J. Lemieux, S. Slaymaker, K. Vaddi, I. Charo, R. L. Leibel, and A. W. Ferrante, Jr. 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116: 115-124.
10. Han, M. S., D. Y. Jung, C. Morel, S. A. Lakhani, J. K. Kim, R. A. Flavell, and R. J. Davis. 2013. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339: 218-222.
11. Patsouris, D., P. P. Li, D. Thapar, J. Chapman, J. M. Olefsky, and J. G. Neels. 2008. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 8: 301-309.
12. Kamei, N., K. Tobe, R. Suzuki, M. Ohsugi, T.Watanabe, N. Kubota, N. Ohtsuka-Kowatari, K. Kumagai, K. Sakamoto, M. Kobayashi, et al. 2006. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 281: 26602-26614.
13. Feuerer, M., L. Herrero, D. Cipolletta, A. Naaz, J. Wong, A. Nayer, J. Lee, A. B. Goldfine, C. Benoist, S. Shoelson, and D. Mathis. 2009. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15: 930-939.
14. Nishimura, S., I. Manabe, M. Nagasaki, K. Eto, H. Yamashita, M. Ohsugi, M. Otsu, K. Hara, K. Ueki, S. Sugiura, et al. 2009. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15: 914-920.
15. Winer, S., Y. Chan, G. Paltser, D. Truong, H. Tsui, J. Bahrami, R. Dorfman, Y. Wang, J. Zielenski, F. Mastronardi, et al. 2009. Normalization of obesityassociated insulin resistance through immunotherapy. Nat. Med. 15: 921-929.
16. Rocha, V. Z., E. J. Folco, G. Sukhova, K. Shimizu, I. Gotsman, A. H. Vernon, and P. Libby. 2008. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 103: 467-476.
17. Xu, X., A. Grijalva, A. Skowronski, M. van Eijk, M. J. Serlie, and A. W. Ferrante, Jr. 2013. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 18: 816-830.
18. Baggio, L. L., and D. J. Drucker. 2007. Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157.
19. Paschetta, E., M. Hvalryg, and G. Musso. 2011. Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesityassociated disorders. Obes. Rev. 12: 813-828.
20. Kim, S. J., C. Nian, and C. H. McIntosh. 2007. Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. J. Biol. Chem. 282: 8557-8567.
21. Gögebakan, Ö., J. Andres, K. Biedasek, K. Mai, P. Kuhnen, H. Krude, F. Isken, N. Rudovich, M. A. Osterhoff, U. Kintscher, et al. 2012. Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11bhydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids. Diabetes 61: 292-300.
22. Song, D. H., L. Getty-Kaushik, E. Tseng, J. Simon, B. E. Corkey, and M. M. Wolfe. 2007. Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation. Gastroenterology 133: 1796-1805.
23. Kim, S. J., C. Nian, S. Karunakaran, S. M. Clee, C. M. Isales, and C. H. McIntosh. 2012. GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis. PLoS ONE 7: e40156.
24. Nogi, Y., M. Nagashima, M. Terasaki, K. Nohtomi, T. Watanabe, and T. Hirano. 2012. Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice. PLoS ONE 7: e35683.
25. Nagashima, M., T. Watanabe, M. Terasaki, M. Tomoyasu, K. Nohtomi, J. Kim- Kaneyama, A. Miyazaki, and T. Hirano. 2011. Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia 54: 2649-2659.
26. Lamont, B. J., and D. J. Drucker. 2008. Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice. Diabetes 57: 190-198.
27. Szalowska, E., K. Meijer, N. Kloosterhuis, F. Razaee, M. Priebe, and R. J. Vonk. 2011. Sub-chronic administration of stable GIP analog in mice decreases serum LPL activity and body weight. Peptides 32: 938-945.
28. Zigmond, E., S. Samia-Grinberg, M. Pasmanik-Chor, E. Brazowski, O. Shibolet, Z. Halpern, and C. Varol. 2014. Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. J. Immunol. 193: 344-353.
29. Zigmond, E., C. Varol, J. Farache, E. Elmaliah, A. T. Satpathy, G. Friedlander, M. Mack, N. Shpigel, I. G. Boneca, K. M. Murphy, et al. 2012. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37: 1076-1090.
30. Puri, V., S. Ranjit, S. Konda, S. M. Nicoloro, J. Straubhaar, A. Chawla, M. Chouinard, C. Lin, A. Burkart, S. Corvera, et al. 2008. Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc. Natl. Acad. Sci. USA 105: 7833-7838.
31. Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
32. Nov, O., A. Kohl, E. C. Lewis, N. Bashan, I. Dvir, S. Ben-Shlomo, S. Fishman, S. Wueest, D. Konrad, and A. Rudich. 2010. Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation. Endocrinology 151: 4247-4256.
33. Tilg, H., and G. S. Hotamisligil. 2006. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131: 934-945.
34. Matsubara, T., A. Mita, K. Minami, T. Hosooka, S. Kitazawa, K. Takahashi, Y. Tamori, N. Yokoi, M. Watanabe, E. Matsuo, et al. 2012. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metab. 15: 38-50.
35. Yavropoulou, M. P., and J. G. Yovos. 2013. Incretins and bone: evolving concepts in nutrient-dependent regulation of bone turnover. Hormones (Athens) 12: 214-223.
36. Bates, H. E., J. E. Campbell, J. R. Ussher, L. L. Baggio, A. Maida, Y. Seino, and D. J. Drucker. 2012. Gipr is essential for adrenocortical steroidogenesis; however, corticosterone deficiency does not mediate the favorable metabolic phenotype of Gipr(2/2) mice. Diabetes 61: 40-48.
37. Kollet, O., Y. Vagima, G. D'Uva, K. Golan, J. Canaani, T. Itkin, S. Gur-Cohen, A. Kalinkovich, G. Caglio, C. Medaglia, et al. 2013. Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors. Leukemia 27: 2006-2015.
38. Nagareddy, P. R., M. Kraakman, S. L. Masters, R. A. Stirzaker, D. J. Gorman, R. W. Grant, D. Dragoljevic, E. S. Hong, A. Abdel-Latif, S. S. Smyth, et al. 2014. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab. 19: 821-835.